When a decision is to be made on whether someone should get started on [medication] or not, so I feel like this [study] will be very helpful concerning those discussions. We are building evidence that hopefully can be built into prediction models to help patients estimate, based on their individual circumstances, what is the most likely range of weight reduction given their persistence, BMI, sex, medication they are about to start at the time of decision-making on which GLP-1 medication to choose, or whether to choose pharmacotherapy or another modality for the treatment of obesity, Gasoyan said
Once approved, patients receive a monthly shipment of their compounded semaglutide or name-brand alternative, depending on their plan
Semaglutide has also shown potential benefits for cardiovascular health, lowering the risk of major cardiovascular events in patients with type 2 diabetes
Having overweight or obesity can contribute to hormonal imbalances, insulin resistance, chronic inflammation, and altered reproductive hormone signaling, all of which may impair fertility
